Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02626845 · ClinicalTrials.gov registry record · Phase 4
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02626845: Clinical Trial Phase 4 study, sponsored by Hospital for Special Surgery, New York.
NCT02626845 is a Phase 4 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02626845, a Phase 4 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a phase IV, single-center, randomized, placebo-controlled pilot study that will evaluate the efficacy of rituximab at inducing otolaryngologic remission in GPA patients with active otolaryngologic disease.
Primary Outcome
ENT remission is defined as a GPA ENT disease activity score of 0.
Interventions
- OTHER Placebo
- DRUG Rituximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
Why NCT02626845 stopped before completion
NCT02626845 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02626845 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02626845 about?
NCT02626845 is a clinical study titled "Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis". This is a phase IV, single-center, randomized, placebo-controlled pilot study that will evaluate the efficacy of rituximab at inducing otolaryngologic remission in GPA patients with active otolaryngologic disease.
What is the current status of trial NCT02626845?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2015-12. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02626845?
The interventions under investigation include: Placebo (OTHER), Rituximab (DRUG).
Who is sponsoring clinical trial NCT02626845?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02626845's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia